,
,
,
,
,
,
,
,
TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in nonsmall cell lung cancer, Cancer Res, vol.74, issue.18, pp.5008-5026, 2014. ,
,
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function. Cell Rep, vol.12, pp.244-57, 2015. ,
COX-2 promotes suppressor cells, Oncoimmunology, vol.4, issue.11, p.1044712, 2015. ,
,
,
,
, J Clin Oncol Off J Am Soc Clin Oncol, vol.25, issue.18, pp.2546-53, 2007.
Reduced limits tumor progression. Cancer Res, vol.67, pp.10019-10045, 2007. ,
CCL2 blockade augments cancer immunotherapy, Cancer Res, vol.70, issue.1, pp.109-127, 2010. ,
Mechanisms and functional significance of tumour-induced dendritic ,
MDSCs in cancer: Conceiving new prognostic and therapeutic targets, Biochim Biophys Acta, 2016. ,
Immune cell promotion of metastasis, Nat Rev Immunol, vol.15, issue.2, pp.73-86, 2015. ,
Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation, J Oncol, p.201026, 2010. ,
,
Role of intermediate filaments in migration, invasion and metastasis, Cancer Metastasis Rev, vol.15, issue.4, pp.507-532, 1996. ,
,
The new lung cancer staging system ,
The new World Health Organization classification of lung tumours, Eur Respir J, vol.18, issue.6, pp.1059-68, 2001. ,
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice, Cancer Immunol. Immunother. CII, vol.59, p.47, 2010. ,
, , 2015.
Toll-like receptor agonists in cancer therapy, Immunotherapy, vol.1, pp.949-964, 2009. ,
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant, J. Immunol. Baltim. Md, vol.181, pp.776-784, 1950. ,
Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe, Clin. Cancer Res. Off, 2009. ,
, J. Am. Assoc. Cancer Res, vol.15, pp.425-430
, , 2013.
Toll-like receptors: critical proteins linking innate and acquired immunity, Nat. Immunol, vol.2, pp.675-680, 2001. ,
Pathogen recognition and innate immunity, Cell, vol.124, pp.783-801, 2006. ,
Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3, Nature, vol.413, pp.732-738, 2001. ,
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2, Science, vol.285, pp.736-739, 1999. ,
,
, Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.14, pp.5220-5227
Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-gamma stimulation through a mechanism dependent on endogenous TNFalpha and IL-1alpha, Eur. J. Immunol, vol.30, pp.1263-1271, 2000. ,
Heat shock proteins and toll-like receptors, Handb. Exp. Pharmacol, pp.111-127, 2008. ,
, Exp. Med, vol.204, pp.1037-1047, 2007.
Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization, J. Invest. Dermatol, vol.134, pp.2551-2561, 2014. ,
Prognostic value of tumorinfiltrating CD4+ T-cell subpopulations in head and neck cancers, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.12, pp.465-472, 2006. ,
, , 1986.
, Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells, J. Clin. Invest, vol.78, pp.1316-1323
Dendritic cells and the control of immunity, Nature, vol.392, pp.245-252, 1998. ,
Roles of toll-like receptors in cancer: a double-edged sword for defense and offense, Arch. Pharm. Res, vol.35, pp.1297-1316, 2012. ,
Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis, J. Natl. Cancer Inst, vol.97, pp.1778-1781, 2005. ,
Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer, Cancer Cell, vol.21, pp.822-835, 2012. ,
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan, Lancet Lond. Engl, vol.2, pp.1129-1133, 1981. ,
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers, Adv. Immunol, vol.130, pp.95-190, 2016. ,
Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses, Trends Immunol, vol.23, pp.509-512, 2002. ,
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions, J. Clin. Invest, vol.115, pp.3265-3275, 2005. ,
, , vol.101, pp.1059-1066, 2010.
Ultraviolet radiation damages self noncoding RNA and is detected by TLR3, Nat. Med, vol.18, pp.1286-1290, 2012. ,
Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer, Int. J. Cancer, vol.139, pp.1129-1139, 2016. ,
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2, J. Immunol. Baltim. Md, pp.3470-3478, 2016. ,
Tlr4: central component of the sole mammalian LPS sensor, Curr. Opin. Immunol, vol.12, pp.20-26, 2000. ,
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF, 2006. ,
, /STAT1 activation), Blood, vol.107, pp.2112-2122
, , 2005.
, , 1998.
,
The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products, J. Leukoc. Biol, vol.67, pp.508-514, 2000. ,
Phase I study of singleagent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.28, pp.3167-3175, 2010. ,
Impact of Tumor-Derived CCL2 on Macrophage Effector Function, J. Biomed. Biotechnol, pp.37-43, 2005. ,
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors, Science, vol.285, pp.732-736, 1999. ,
Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma, Cancer Res, vol.70, pp.9816-9826, 2010. ,
Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death, 1999. ,
, J. Immunol. Baltim. Md, vol.162, pp.3356-3366, 1950.
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells, J. Immunol. Baltim. Md, vol.161, pp.5313-5320, 1950. ,
,
, Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation, J. Immunol. Baltim. Md, vol.162, pp.5728-5737, 1950.
, , 2000.
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice, J. Immunol. Baltim. Md, vol.170, pp.270-278, 1950. ,
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards, Nat. Commun, vol.7, p.12150, 2016. ,
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression, J. Immunol. Baltim. Md, vol.176, pp.284-290, 1950. ,
, , 2009.
,
, Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy, Int. J. Radiat. Oncol. Biol. Phys, vol.83, pp.228-234
Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma, Leuk. Lymphoma, vol.52, pp.1230-1238, 2011. ,
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial, J. Cancer Res. Clin. Oncol, vol.137, pp.1337-1342, 2011. ,
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, Lancet Oncol, vol.15, pp.59-68, 2014. ,
Activation of TollRes, vol.71, pp.2466-2475, 2011. ,
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker, J. Transl. Med, vol.8, 2010. ,
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells, J. Clin. Invest, vol.120, pp.457-471, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00451697
T helper 17 cells play a critical pathogenic role in lung cancer, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.5664-5669, 2014. ,
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma, Science, vol.266, pp.1865-1869, 1994. ,
TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer, Cancer Res, vol.74, pp.5008-5018, 2014. ,
NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target, Front. Biosci. Landmark Ed, vol.16, pp.1172-1185, 2011. ,
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients, Lung Cancer Amst. Neth, vol.69, pp.348-354, 2010. ,
Significance of TLR4/MyD88 expression in breast cancer, Int. J. Clin. Exp. Pathol, vol.8, pp.7034-7039, 2015. ,
, , 2012.
, , 2010.
, J. Clin. Invest, vol.120, pp.1285-1297
Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients, J. Natl. Cancer Inst, vol.104, pp.1796-1807, 2012. ,
, , 2007.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, vol.244, pp.359-362, 1989. ,
, Int. J. Cancer, vol.136, pp.1341-1350, 2015.
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function, Cell Rep, vol.12, pp.244-257, 2015. ,
Inflammatory mediators in chronic obstructive pulmonary disease, Curr. Drug Targets Inflamm. Allergy, vol.4, pp.619-625, 2005. ,
Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown, 2002. ,
, Crit. Care Med, vol.166, pp.849-854
Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3, Oncogene, vol.19, pp.1123-1131, 2000. ,
Regulation of Tumor Metastasis by Myeloid-derived Suppressor Cells, Annu. Rev. Med, vol.66, pp.97-110, 2015. ,
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, vol.124, pp.263-266, 2006. ,
, , 2012.
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma, Lung Cancer Amst. Neth, vol.89, p.181, 2015. ,
Inflammation and cancer, Nature, vol.420, pp.860-867, 2002. ,
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis, Cell, vol.103, pp.481-490, 2000. ,
, , 2005.
, Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions, Int. Immunopharmacol, vol.5, pp.1205-1212
Toll-like receptor stimulation in cancer: A pro-and anti-tumor double-edged sword, 2016. ,
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis, Lancet Lond. Engl, vol.1, pp.695-698, 1970. ,
Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4, Cancer Cell, vol.21, pp.504-516, 2012. ,
Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.14, pp.5512-5518, 2008. ,
MDSCs in cancer: Conceiving new prognostic and therapeutic targets, Biochim. Biophys. Acta, vol.1865, pp.35-48, 2016. ,
, , 2009.
The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications, Semin. Oncol, vol.37, pp.499-507, 2010. ,
, TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity, vol.75, pp.1959-1971, 2015.
, , 2014.
, , 2015.
The biological properties of E6 and E7 oncoproteins from human papillomaviruses, Virus Genes, vol.40, pp.1-13, 2010. ,
The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer, Cancer Treat. Res, vol.115, pp.241-265, 2003. ,
, , 2014.
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer, vol.2, pp.706-714, 2007. ,
, , 2002.
Granulocytemacrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway, J. Immunol. Baltim. Md, vol.171, pp.6846-6855, 1950. ,
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence, Cancer Immunol. Immunother. CII, vol.60, pp.217-226, 2011. ,
Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation, J. Immunol. Baltim. Md, vol.163, p.403, 1950. ,
Role of NK cells in the control of metastatic spread and growth of tumor cells in mice, Int. J. Cancer, vol.30, pp.107-112, 1982. ,
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors, Mol. Cancer Ther, vol.7, pp.3642-3653, 2008. ,
Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression, Eur. J. Cancer Oxf. Engl, vol.46, pp.2849-2857, 1990. ,
TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer, Int. J. Oncol, vol.47, pp.857-866, 2015. ,
, Immunity, inflammation, and cancer. Cell, vol.140, pp.883-899, 2010.
, , pp.2215-2225, 2015.
Metabolic reprogramming of cancer-associated fibroblasts by TGF-? drives tumor growth: connecting TGF-? signaling with "Warburg-like" cancer metabolism and L-lactate production, Cell Cycle Georget. Tex, vol.11, pp.3019-3035, 2012. ,
RNA recognition by human TLR8 can lead to autoimmune inflammation, J. Exp. Med, vol.210, pp.2903-2919, 2013. ,
, , 2005.
Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2, PloS One, vol.10, 2015. ,
Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression--clinicopathological correlation, Gynecol. Oncol, vol.105, pp.157-165, 2007. ,
The hallmarks of cancer, Cell, vol.100, pp.57-70, 2000. ,
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011. ,
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation, Gastroenterology, vol.122, 1987. ,
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, vol.410, pp.1099-1103, 2001. ,
, Immunol, vol.44, pp.2850-2859, 2007.
, , vol.303, pp.1526-1529, 2004.
, Gastric cancer and Helicobacter pylori, 2001.
A Toll-like receptor recognizes bacterial DNA, Nature, vol.408, pp.740-745, 2000. ,
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway, Nat. Immunol, vol.3, pp.196-200, 2002. ,
Role of intermediate filaments in migration, invasion and metastasis, Cancer Metastasis Rev, vol.15, pp.507-525, 1996. ,
, , 2003.
Control of Bcl-2 expression by reactive oxygen species, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.15035-15040, 2003. ,
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression, Oncotarget, 2015. ,
, , 2008.
Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells, Respir. Res, vol.14, p.97, 2013. ,
How imiquimod licenses plasmacytoid dendritic cells to kill tumors, Oncoimmunology, vol.1, pp.1661-1663, 2012. ,
Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance, Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg, vol.14, pp.2467-2477, 2014. ,
Mammalian Toll-like receptors: to immunity and beyond, Clin. Exp. Immunol, vol.140, pp.395-407, 2005. ,
Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells, J. Exp. Med, vol.198, pp.1225-1235, 2003. ,
, , 2002.
, J. Immunol. Baltim. Md, vol.168, pp.4531-4537, 1950.
Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7, Nat. Med, vol.11, pp.263-270, 2005. ,
5'-Triphosphate RNA is the ligand for RIG-I, Science, vol.314, pp.994-997, 2006. ,
Pillars Article: Cutting Edge: Toll-Like Receptor 4 (TLR4)-Deficient Mice Are Hyporesponsive to Lipopolysaccharide: Evidence for TLR4 as the Lps Gene Product, J. Immunol. Baltim. Md, vol.162, pp.2563-2566, 1999. ,
, , 2015.
, , 2005.
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host, Cancer Res, vol.66, pp.1123-1131, 2006. ,
, , 2007.
TLR signaling by tumor and immune cells: a double-edged sword, Oncogene, vol.27, pp.218-224, 2008. ,
, , 2005.
Upregulation of TLR7 and TLR3 gene expression in the lung of respiratory syncytial virus infected mice, Wei Sheng Wu Xue Bao, vol.49, pp.239-245, 2009. ,
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma, Curr. Opin. Oncol, vol.26, pp.237-244, 2014. ,
Role of toll-like receptors in cervical, endometrial and ovarian cancers: a review, Gynecol. Oncol, vol.135, pp.359-363, 2014. ,
mutations: the Okayama Lung Cancer Study Group Trial 1001, J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer, vol.10, pp.486-491, 2015. ,
S100A8/A9 activate key genes and pathways in colon tumor progression, Mol. Cancer Res. MCR, vol.9, p.133, 2011. ,
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population, Lancet Lond. Engl, vol.356, pp.1795-1799, 2000. ,
, , 2005.
, Anticancer Res, vol.25, pp.2027-2031
Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells, J. Leukoc. Biol, vol.77, pp.378-387, 2005. ,
, TLR4 Prostate, vol.75, pp.1020-1033, 2015.
Approaching the asymptote? Evolution and revolution in immunology, Cold Spring Harb. Symp. Quant. Biol. 54 Pt, vol.1, pp.1-13, 1989. ,
, , 2006.
, Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors, Leukemia, vol.20, pp.1130-1137
, Poly I:C enhances cycloheximide-induced apoptosis, 2008.
, , 1998.
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice, Nature, vol.410, pp.1111-1116, 2001. ,
Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice, J. Clin. Invest, vol.110, pp.1539-1548, 2002. ,
Microenvironmental regulation of metastasis, Nat. Rev. Cancer, vol.9, pp.239-252, 2009. ,
TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod-and IFN-?-mediated antitumor reactivity, J. Immunol. Baltim. Md, vol.188, pp.1583-1591, 1950. ,
, , 2011.
Nuclear factor-kappaB in cancer development and progression, Nature, vol.441, pp.431-436, 2006. ,
Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2, Nat. Immunol, vol.9, pp.684-691, 2008. ,
The role of pattern-recognition receptors in innate immunity, 2010. ,
, , 1996.
Biological aspects of monocyte chemoattractant protein-1 (MCP-1), Adv. Exp. Med. Biol, vol.305, pp.57-64, 1991. ,
Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1, J. Immunol. Baltim. Md, vol.182, pp.240-249, 1950. ,
TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression, Cancer Res, vol.75, pp.986-995, 2015. ,
, , 2016.
, Res, vol.66, pp.11238-11246, 2006.
,
Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice, J. Clin. Invest, vol.118, pp.1165-1175, 2008. ,
Aberrant frequency of IL-10-producing B cells and its association with Treg and MDSC cells in Non Small Cell Lung Carcinoma patients, Hum. Immunol, vol.77, pp.84-89, 2016. ,
,
, Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9, J. Hepatol, vol.63, pp.114-121
Harnessing the antitumor potential of macrophages for cancer immunotherapy, Oncoimmunology, vol.2, p.26860, 2013. ,
, , p.13027, 2010.
, Recognition of single-stranded RNA viruses by Toll-like receptor 7, 2004.
, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.5598-5603
,
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.30, pp.2046-2054, 2012. ,
, , 2014.
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers, OncoTargets Ther, vol.6, pp.1573-1587, 2013. ,
Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus, Proc. Natl. Acad. Sci. U. S. A, vol.107, pp.11531-11536, 2010. ,
The origin and function of tumor-associated macrophages, Immunol. Today, vol.13, pp.265-270, 1992. ,
Cancer-related inflammation, Nature, vol.454, pp.436-444, 2008. ,
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor, Immunity, vol.32, pp.790-802, 2010. ,
Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family, Biochim. Biophys. Acta, vol.1592, pp.265-280, 2002. ,
, , 2015.
, Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling, Biochem. Biophys. Res. Commun, vol.457, pp.445-450
Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation, PLoS Pathog, vol.8, p.1002841, 2012. ,
Functionally active toll-like receptor 3 on human primary and metastatic cancer cells, Scand. J. Immunol, vol.70, pp.18-24, 2009. ,
Myeloid suppressor lines inhibit T cell responses by an NOdependent mechanism, J. Immunol. Baltim. Md, vol.168, pp.689-695, 1950. ,
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature, vol.388, pp.394-397, 1997. ,
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice, J. Clin. Invest, vol.118, pp.2516-2525, 2008. ,
IFNs activate toll-like receptor gene expression in viral infections, Genes Immun, vol.2, pp.349-355, 2001. ,
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors, PloS One, vol.4, p.6412, 2009. ,
Endotoxin recognition molecules, Toll-like receptor 4-MD-2, Semin. Immunol, vol.16, pp.11-16, 2004. ,
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma, N. Engl. J. Med, vol.361, pp.947-957, 2009. ,
Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4, Cancer Lett, vol.235, pp.75-83, 2006. ,
, GM-CSF, 2010.
TLR9 signaling through NF-?B/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells, Oncotarget, vol.6, pp.17302-17313, 2015. ,
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies, Front. Immunol, vol.5, p.341, 2014. ,
,
, Toll-like receptors in normal and cystic fibrosis airway epithelial cells, Am. J. Respir. Cell Mol. Biol, vol.30, pp.777-783
The role of myeloid cells in the promotion of tumour angiogenesis, Nat. Rev. Cancer, vol.8, pp.618-631, 2008. ,
Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand, J. Immunol. Baltim. Md, vol.171, pp.3977-3982, 1950. ,
Surface markers of NK cells in peripheral blood of patients with cirrhosis and hepatocellular carcinoma, Immunol. Lett, vol.13, pp.7-10, 1986. ,
, , 1997.
, , 2012.
, Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice, Int. J. Cancer J. Int. Cancer, vol.130, pp.765-774
Melanoma and innate immunity--aActive inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines, Semin. Cancer Biol, vol.19, pp.84-91, 2009. ,
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines, Am. J. Pathol, vol.150, pp.1723-1734, 1997. ,
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer, Cytokine Growth Factor Rev, vol.22, pp.83-89, 2011. ,
Signaling in innate immunity and inflammation, Cold Spring Harb. Perspect. Biol, vol.4, 2012. ,
, CD20+ tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer, 2012.
, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.18, pp.3281-3292
, , 2010.
Asbestos-related lung disease: a pictorial review, Curr. Probl. Diagn. Radiol, vol.44, pp.371-382, 2015. ,
, , 2011.
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, J. Clin. Invest, vol.122, pp.4118-4129, 2012. ,
Effects of L-arginine on the proliferation of T lymphocyte subpopulations, JPEN J. Parenter. Enteral Nutr, vol.25, pp.23-29, 2001. ,
Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK, 2003. ,
, J. Natl. Cancer Inst, vol.95, pp.316-326
, , 2015.
Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4, 2011. ,
, + T cells to T-regulatory cells, Cancer Res, vol.71, pp.3505-3515
, , 1999.
Human TLR10 is an anti-inflammatory pattern-recognition receptor, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.4478-4484, 2014. ,
, , 2005.
, , 2000.
,
, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.1, pp.95-103
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism, Carcinogenesis, vol.29, pp.1334-1342, 2008. ,
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell, vol.140, pp.197-208, 2010. ,
Tolllike receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma, 2011. ,
, J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol, vol.40, pp.187-193
The global health burden of infection-associated cancers in the year 2002, Int. J. Cancer, vol.118, pp.3030-3044, 2006. ,
,
, J. Am. Soc. Nephrol. JASN, vol.18, pp.1721-1731
,
, J. Immunol. Baltim. Md, vol.178, pp.2763-2769, 1950.
Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients, Cancer, vol.107, pp.2866-2872, 2006. ,
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates, Science, vol.314, pp.997-1001, 2006. ,
NF-kappaB functions as a tumour promoter in inflammation-associated cancer, Nature, vol.431, pp.461-466, 2004. ,
Cellular manifestations of human papillomavirus infection in the oral mucosa, J. Surg. Oncol, vol.71, p.10, 1999. ,
Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia, Pathol. Oncol. Res. POR, vol.17, pp.677-683, 2011. ,
,
, Virol, vol.72, pp.1165-1170
Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma, Cancer Res, vol.71, pp.5412-5422, 2011. ,
cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci. U. S. A, vol.77, pp.7415-7419, 1980. ,
Tumour-educated macrophages promote tumour progression and metastasis, Nat. Rev. Cancer, vol.4, pp.71-78, 2004. ,
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, vol.282, pp.2085-2088, 1998. ,
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth, Cancer Immunol. Immunother. CII, vol.61, pp.1373-1385, 2012. ,
, , 2015.
B cells inhibit induction of T cell-dependent tumor immunity, Nat. Med, vol.4, pp.627-630, 1998. ,
Nitric oxide, oxidants, and protein tyrosine nitration, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.4003-4008, 2004. ,
Why cancer and inflammation? Yale, J. Biol. Med, vol.79, pp.123-130, 2006. ,
Toll-like receptors and cancer, Nat. Rev. Cancer, vol.9, pp.57-63, 2009. ,
Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis, PLoS ONE, vol.7, 2012. ,
Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation, Front. Cell. Infect. Microbiol, vol.3, p.52, 2013. ,
,
, intestinal epithelial cells and macrophages, J. Immunol. Baltim. Md, pp.6084-6092, 1950191.
, , 2008.
The evolution of vertebrate Toll-like receptors, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.9577-9582, 2005. ,
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.6770-6775, 2007. ,
A family of human receptors structurally related to Drosophila Toll, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.588-593, 1998. ,
A new immunodeficiency disorder in humans involving NK cells, Nature, vol.284, pp.553-555, 1980. ,
, , 2004.
Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE, Am. J. Pathol, vol.136, pp.1229-1233, 1990. ,
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma, J. Exp. Clin. Cancer Res. CR, vol.30, p.84, 2011. ,
Screening for epidermal growth factor receptor mutations in lung cancer, N. Engl. J. Med, vol.361, pp.958-967, 2009. ,
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutationpositive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial, Lancet Oncol, vol.13, pp.239-246, 2012. ,
, , 2015.
Tumor necrosis factor-? blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation, Immunity, vol.38, pp.541-554, 2013. ,
Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin, Cancer Res. Off. J. Am, 2007. ,
, Cancer Res, vol.13, pp.4565-4574
, , 2015.
, Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors, Mol. Cancer Ther, vol.14, pp.2198-2205
Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment, Cancer Microenviron. Off. J. Int. Cancer Microenviron. Soc, vol.2, pp.205-214, 2009. ,
Natural killer cell activity and head and neck cancer: a clinical assessment, J. Natl. Cancer Inst, vol.77, pp.869-875, 1986. ,
A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis, Nat. Cell Biol, vol.16, pp.1238-1248, 2014. ,
, , 2005.
, Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori, Int. J. Med. Microbiol. IJMM, vol.295, pp.179-185
Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation, J. Oncol, 2010. ,
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups, PloS One, vol.10, 2015. ,
, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.18, pp.2695-2703, 2012.
NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?, Trends Biochem. Sci, vol.28, pp.646-654, 2003. ,
Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis, Am. J. Pathol, vol.161, pp.947-956, 2002. ,
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe, Br. J. Dermatol, vol.152, pp.939-947, 2005. ,
Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts, Eur. J. Immunol, vol.25, pp.1129-1132, 1995. ,
Highdose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells, Cancer Res, vol.64, pp.6337-6343, 2004. ,
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study, Lancet Oncol, vol.15, pp.1236-1244, 2014. ,
The impact of imiquimod, 2004. ,
Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells, Int. J. Cancer, vol.117, pp.574-586, 2005. ,
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, vol.410, pp.1107-1111, 2001. ,
Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway, Cancer Lett, vol.355, pp.264-272, 2014. ,
NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy, Apoptosis Int. J. Program. Cell Death, vol.14, pp.348-363, 2009. ,
Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med, vol.35, pp.9627-9637, 2014. ,
, , 2014.
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.2066-2071, 2012. ,
, Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity, 1999.
, J. Immunol. Baltim. Md, vol.163, pp.5211-5218, 1950.
, , 2010.
, , 2009.
Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages, J. Immunol. Baltim. Md, vol.164, pp.762-767, 1950. ,
Cancer related inflammation: the macrophage connection, Cancer Lett, vol.267, pp.204-215, 2008. ,
A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alpha, Proc. Natl. Acad. Sci. U. S. A, vol.107, pp.3046-3051, 2010. ,
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease, J. Immunol. Baltim. Md, vol.174, pp.636-645, 1950. ,
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells, Cancer Res, vol.67, pp.4507-4513, 2007. ,
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells, Eur. J. Immunol, vol.23, pp.2692-2695, 1993. ,
, , 2012.
The role of ubiquitin in NF-kappaB regulatory pathways, Annu. Rev. Biochem, vol.78, pp.769-796, 2009. ,
, , 1987.
Activation of NK cell cytotoxicity, Mol. Immunol, vol.42, pp.501-510, 2005. ,
Transcription factors in myeloid-derived suppressor cell recruitment and function, Curr. Opin. Immunol, vol.23, pp.279-285, 2011. ,
, , 2011.
CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells, J. Immunol. Baltim. Md, vol.175, p.8200, 1950. ,
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer, J. Clin. Invest, vol.100, pp.2952-2960, 1997. ,
Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells, Leukemia, vol.20, pp.286-295, 2006. ,
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, vol.6, pp.447-458, 2004. ,
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases, J. Clin. Oncol, vol.30, pp.419-425, 2012. ,
,
, Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine, Cancer Res, vol.70, pp.68-77
, , 2012.
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells, J. Exp. Med, vol.204, pp.1441-1451, 2007. ,
Tumor cell interactions with the extracellular matrix during invasion and metastasis, Annu. Rev. Cell Biol, vol.9, p.541, 1993. ,
Neoplasms in mice inoculated with a tumor agent carried in tissue culture, J. Natl. Cancer Inst, vol.20, pp.1223-1243, 1958. ,
, , 1980.
Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses, Eur. J. Immunol, vol.42, pp.2060-2072, 2012. ,
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4, Nature, vol.416, pp.750-756, 2002. ,
Immune surveillance of tumors, J. Clin. Invest, vol.117, pp.1137-1146, 2007. ,
Condylomatous changes in neoplastic bronchial epithelium, Int. Rev. Thorac. Dis, vol.38, pp.299-304, 1979. ,
Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma, Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-RhinoLaryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. -Head Neck Surg, vol.264, p.525, 2007. ,
, , 2009.
STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation, Cancer Cell, vol.22, pp.466-478, 2012. ,
Massspectrometric characterization of peroxidized and hydrolyzed lipids in plasma and dendritic cells of tumor-bearing animals, Biochem. Biophys. Res. Commun, vol.413, pp.149-153, 2011. ,
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens, Nature, vol.401, pp.811-815, 1999. ,
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells, Nature, vol.335, pp.440-442, 1988. ,
Programmed death ligand-1 expression in non-small cell lung cancer, Lab. Investig. J. Tech. Methods Pathol, vol.94, pp.107-116, 2014. ,
, , 2010.
Innate or adaptive immunity? The example of natural killer cells, Science, vol.331, pp.44-49, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00611585
Perforin and granzymes: function, dysfunction and human pathology, Nat. Rev. Immunol, vol.15, pp.388-400, 2015. ,
Regulation of perforin-independent NK cell-mediated cytotoxicity, Eur. J. Immunol, vol.33, pp.2727-2735, 2003. ,
,
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway, J. Exp. Med, vol.206, p.1457, 2009. ,
, , 2013.
, /A9 proinflammatory proteins, J. Immunol. Baltim. Md, pp.794-804, 1950190.
CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer, Oncotarget, vol.6, pp.33486-33499, 2015. ,
Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med, vol.37, pp.6581-6588, 2016. ,
, , 2014.
, , 2012.
, J. Mol. Med. Berl. Ger, vol.90, pp.1343-1355
, Am. J. Respir. Crit. Care Med, vol.178, pp.1123-1129, 2008.
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, Nat. Med, vol.15, pp.1016-1022, 2009. ,
Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells, Biochem. Biophys. Res. Commun, vol.379, pp.1027-1032, 2009. ,
Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model, Mol. Med. Rep, vol.8, pp.1037-1042, 2013. ,
,
, TNF?-induced M-MDSCs promote transplant immune tolerance via nitric oxide, J. Mol. Med. Berl. Ger, vol.94, pp.911-920
). inflammatory cytokines secretion, J. Exp. Clin. Cancer Res. CR, vol.29, p.92, 2010. ,
, , 2014.
Possible cofactor in cervical carcinogenesis: proliferation index of the transformation zone in cervicitis, 2001. ,
, J, vol.24, pp.615-620
Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways, Lung, vol.189, pp.453-460, 2011. ,
Growth factor receptor tyrosine kinases, Annu. Rev. Biochem, vol.57, pp.443-478, 1988. ,
, , 2014.
Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis, Int. J. Oncol, vol.33, pp.929-936, 2008. ,
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease, Proc. Natl, 1982. ,
The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity, Eur. J. Immunol, vol.40, pp.2969-2975, 2010. ,
Link between COPD and lung cancer, Respir. Med, vol.104, pp.758-759, 2010. ,
STATs in cancer inflammation and immunity: a leading role for STAT3, Nat. Rev. Cancer, vol.9, pp.798-809, 2009. ,
Opposite Effects of M1 and M2 Macrophage Subtypes on, Lung Cancer Progression. Sci. Rep, vol.5, p.14273, 2015. ,
,
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis, J. Exp. Med, vol.212, pp.2077-2094, 2015. ,
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion, Cancer Res, vol.65, pp.3044-3048, 2005. ,
Clodronate-liposome-mediated depletion of tumourassociated macrophages: a new and highly effective antiangiogenic therapy approach, Br. J. Cancer, vol.95, pp.272-281, 2006. ,
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis, Cytokine Growth Factor Rev, vol.21, pp.41-48, 2010. ,
, , 2011.
, J. Immunol. Baltim. Md, vol.186, pp.1963-1969, 1950.
Functional expression of TLR9 in esophageal cancer, Oncol. Rep, vol.31, pp.2298-2304, 2014. ,
Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis, PloS One, vol.9, p.95884, 2014. ,
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study, Lancet Oncol, vol.12, pp.735-742, 2011. ,
Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer, J. Transl. Med, vol.12, p.304, 2014. ,
, J. Cancer Prev. APJCP, vol.13, pp.2807-2812, 2012.
, CD19(+)IL-10(+), 2016.
TLR7/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma, Cancer Lett, 2015. ,
, , 2015.
Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy, 2016. ,
,
, Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colonystimulating activity and prostaglandin E2, J. Clin. Invest, vol.77, pp.1857-1863
, Institut National Du Cancer -Accueil
Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8, Mol Cancer Ther, vol.9, issue.6, pp.1788-97, 2010. ,
Intratracheal and oral administration of SM-276001: a selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer, Int J Cancer J Int Cancer, vol.132, issue.3, pp.580-90, 2013. ,
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment, Cancer Res, vol.73, issue.15, pp.4629-4669, 2013. ,
,
A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes, J Am Acad Dermatol, vol.66, issue.4, pp.131-138, 2012. ,
Immunomodulation by imiquimod in patients with high-risk primary melanoma, J Invest Dermatol, vol.132, issue.1, pp.163-172, 2012. ,
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance, J Clin Invest, vol.120, issue.4, pp.1285-97, 2010. ,
TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer, Cancer Res, vol.74, issue.18, p.25074614, 2014. ,
,
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, J Clin Invest, vol.122, issue.11, pp.4118-4147, 2012. ,
Effect of tolllike receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma, Liver Int Off J Int Assoc Study Liver, 2014. ,
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer, Cancer Res, vol.66, issue.7, pp.3859-68, 2006. ,
, 1. Anti-and pro-tumoral effects of TLR stimulation (Table 2)
,
,
,
,
,
,
,
, Muccioli and Benencia, p.10, 2002.
, Huen and Rook, 2002.
, pDC, plasmacytoid dendritic cells; cDC, conventional dendritic cells; NK, natural killer
,
Two studies of intestinal carcinoma reported that TLR2 had proor anti-tumoral effects. The first, favoring an anti-tumoral role of TLR2, demonstrated increased tumor progression and increased pro-inflammatory cytokines in a TLR2-KO mouse model of carcinogenesis created by dextran sulfate sodium, However, these studies were not based on the same tumor models, 2007. ,
Toll-like receptor agonists in cancer therapy, Immunotherapy, vol.1, pp.949-964, 2009. ,
Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer, Ann. Surg. Oncol, vol.20, pp.389-396, 2013. ,
Pathogen recognition and innate immunity, Cell, vol.124, pp.783-801, 2006. ,
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nat. Med, vol.13, pp.1050-1059, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00316924
Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization, J. Invest. Dermatol, vol.134, pp.2551-2561, 2014. ,
Cancer: an inflammatory link, Nature, vol.431, pp.405-406, 2004. ,
Inflammation and cancer: back to Virchow?, Lancet Lond. Engl, vol.357, pp.539-545, 2001. ,
Toll-like receptor modulators: a patent review, Expert Opin. Ther. Pat, vol.21, pp.927-944, 2006. ,
Roles of Toll-like receptors in cancer: a double-edged sword for defense and offense, Arch. Pharm. Res, vol.35, pp.1297-1316, 2012. ,
Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis, 2005. ,
, J. Natl. Cancer Inst, vol.97, pp.1778-1781
Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses, Trends Immunol, vol.23, pp.509-512, 2002. ,
Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer, Int. J. Cancer J. Int. Cancer, vol.134, pp.765-777, 2014. ,
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors, Cancer Sci, vol.101, pp.1059-1066, 2010. ,
DAMPs, PAMPs and alarmins: all we need to know about danger, J. Leukoc. Biol, vol.81, pp.1-5, 2007. ,
Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma, Cancer Res, vol.70, pp.9816-9826, 2010. ,
Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy, Int. J. Radiat. Oncol. Biol. Phys, vol.83, pp.228-234, 2012. ,
Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth, Cancer Res, vol.71, pp.2466-2475, 2011. ,
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker, Pattern-recognition receptors and gastric cancer. Front. Immunol, vol.8, p.336, 2010. ,
TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer, Cancer Res, vol.74, pp.5008-5018, 2014. ,
Inflammation, cancer and chemoresistance: taking advantage of the Toll-like receptor signaling pathway, Am. J. Reprod. Immunol. N. Y, vol.198, issue.57, pp.93-107, 2007. ,
Significance of TLR4/MyD88 expression in breast cancer, Int. J. Clin. Exp. Pathol, vol.8, pp.7034-7039, 2015. ,
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance, J. Clin. Invest, vol.120, pp.1285-1297, 2010. ,
, , 2012.
, J. Natl. Cancer Inst, vol.104, pp.1796-1807
The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4, Neurosurgery, vol.60, pp.372-380, 2007. ,
Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance, Cancer Res, vol.70, pp.2595-2603, 2010. ,
Inflammation and cancer, Nature, vol.420, pp.860-867, 2002. ,
Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions, Int. Immunopharmacol, vol.5, pp.1205-1212, 2005. ,
Dual roles of TLR7 in the lung cancer microenvironment. Oncoimmunology 4, e991615, Cancer Cell, vol.21, pp.504-516, 2012. ,
Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy, Clin. Cancer Res, vol.14, pp.5512-5518, 2008. ,
Coordinated tumor immunity, J. Clin. Invest, vol.111, pp.1116-1118, 2003. ,
Human lung cancer cells express functionally active Toll-like receptor 9, Respir. Res, vol.6, p.1, 2005. ,
The three Es of cancer immunoediting, Annu. Rev. Immunol, vol.22, pp.329-360, 2004. ,
Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors, Glia, vol.54, pp.526-535, 2006. ,
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma, Oncotarget, vol.6, pp.9897-9907, 2015. ,
Clinical significance of Toll-like receptor 3, 4, and 9 in gastric cancer, J. Immunother. Hagerstown Md, issue.37, pp.77-83, 1997. ,
Characterization of heme as activator of Toll-like receptor 4, J. Biol. Chem, vol.282, pp.20221-20229, 2007. ,
The immune contexture in human tumours: impact on clinical outcome, Nat. Rev. Cancer, vol.12, pp.298-306, 2012. ,
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors, Gastroenterology, vol.133, pp.1869-1881, 2007. ,
TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo, J. Cell. Mol. Med, vol.19, pp.327-339, 2015. ,
TLR5 ligand-secreting t cells reshape the tumor microenvironment and enhance antitumor activity, Cancer Res, vol.75, pp.1959-1971, 2015. ,
Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma, Cancer Immunol. Immunother. CII, vol.3, pp.217-226, 2011. ,
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer, Cell, vol.118, pp.285-296, 2004. ,
Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression, Eur. J. Cancer Oxf. Engl, issue.46, pp.2849-2857, 1990. ,
TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer, Int. J. Oncol, vol.47, pp.857-866, 2015. ,
The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer, OncoTargets Ther, vol.8, pp.2215-2225, 2015. ,
The hallmarks of cancer, Cell, vol.100, pp.57-70, 2000. ,
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011. ,
Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88, J. Immunol. Baltim. Md, vol.1950, issue.174, pp.2942-2950, 2005. ,
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation, Gastroenterology, vol.122, 1987. ,
TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance, Mol. Immunol, vol.44, pp.2850-2859, 2007. ,
Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2, J. Immunol. Baltim. Md, vol.1950, issue.171, pp.6820-6826, 2003. ,
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression, Oncotarget, 2015. ,
Mammalian Toll-like receptors: to immunity and beyond, Clin. Exp. Immunol, vol.140, pp.395-407, 2005. ,
Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells, J. Exp. Med, vol.198, pp.1225-1235, 2003. ,
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J. Immunol. Baltim. Md, vol.1950, issue.168, pp.4531-4537, 2002. ,
Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells, Cancer Lett, vol.368, pp.144-152, 2015. ,
Toll-like receptors on tumor cells facilitate evasion of immune surveillance, Cancer Res, vol.65, pp.5009-5014, 2005. ,
Listeria monocytogenes promotes tumor growth via tumor cell Toll-like receptor 2 signaling, Cancer Res, vol.67, pp.4346-4352, 2007. ,
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma, Curr. Opin. Oncol, vol.26, pp.237-244, 2014. ,
Role of Toll-like receptors in cervical, endometrial and ovarian cancers: a review, Gynecol. Oncol, vol.135, pp.359-363, 2014. ,
Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells, J. Leukoc. Biol, vol.77, pp.378-387, 2005. ,
TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells, The Prostate, vol.75, pp.1020-1033, 2015. ,
Innate immune recognition, Annu. Rev. Immunol, vol.20, pp.197-216, 2002. ,
Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors, Leukemia, vol.20, pp.1130-1137, 2006. ,
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway, BMC Cancer, vol.8, p.12, 2008. ,
mRNA is an endogenous ligand for Toll-like receptor 3, J. Biol. Chem, vol.279, pp.12542-12550, 2004. ,
Nuclear factor-kappaB in cancer development and progression, Nature, vol.441, pp.431-436, 2006. ,
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat. Immunol, vol.11, pp.373-384, 2010. ,
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer, Cancer Res, vol.66, pp.3859-3868, 2006. ,
The Toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells, The Prostate, vol.68, pp.223-229, 2008. ,
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment, Cancer Res, vol.73, pp.4629-4640, 2013. ,
A flagellin-derived Toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity, PLoS One, vol.9, p.85587, 2014. ,
The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults, Cell, vol.86, pp.973-983, 1996. ,
TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression, Cancer Res, vol.75, pp.986-995, 2015. ,
Microenvironmental interleukin-6 suppresses Toll-like receptor signaling in human leukemia cells through miR-17/19A, Blood, vol.126, pp.766-778, 2015. ,
Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice, Hepatol. Baltim. Md, vol.57, pp.171-182, 2013. ,
Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9, J. Hepatol, vol.63, pp.114-121, 2015. ,
A fate map for the larval epidermis of Drosophila melanogaster: localized cuticle defects following irradiation of the blastoderm with an ultraviolet laser microbeam, Dev. Biol, vol.73, pp.239-255, 1979. ,
Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer, Oncotarget, vol.5, pp.22564-22574, 2010. ,
Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients, PLoS One, vol.9, p.111639, 2014. ,
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers, OncoTargets Ther, vol.6, pp.1573-1587, 2013. ,
Summary and comparison of the signaling mechanisms of the toll/interleukin-1 receptor family, Biochim. Biophys. Acta, vol.1592, pp.265-280, 2002. ,
Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling, Biochem. Biophys. Res. Commun, vol.457, pp.445-450, 2015. ,
Functionally active Toll-like receptor 3 on human primary and metastatic cancer cells, Scand. J. Immunol, vol.70, pp.18-24, 2009. ,
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature, vol.388, pp.394-397, 1997. ,
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways, Mol. Cell, vol.2, pp.253-258, 1998. ,
Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4, Cancer Lett, vol.235, pp.75-83, 2006. ,
TLR9 signaling through NF-(B/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells, Oncotarget, vol.6, pp.17302-17313, 2015. ,
Toll-like receptors in ovarian cancer as targets for immunotherapies, Front. Immunol, vol.5, p.341, 2014. ,
Toll-like receptors in normal and cystic fibrosis airway epithelial cells, Am. J. Respir. Cell Mol. Biol, vol.30, pp.777-783, 2004. ,
Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand, J. Immunol. Baltim. Md, vol.195, issue.171, pp.3977-3982, 2003. ,
Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice, Int. J. Cancer J. Int. Cancer, vol.130, pp.765-774, 2012. ,
Signaling in innate immunity and inflammation, Cold Spring Harb. Perspect. Biol, vol.4, 2012. ,
Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway, Oncol. Rep, vol.24, pp.225-231, 2010. ,
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, J. Clin. Invest, vol.122, pp.4118-4129, 2012. ,
Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432, J. Natl. Cancer Inst, vol.95, pp.316-326, 2003. ,
, Human TLR10 is an anti-inflammatory pattern-recognition receptor, 2014.
, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.4478-4484
Immune infiltration in human tumors: a prognostic factor that should not be ignored, Oncogene, vol.29, pp.1093-1102, 2010. ,
Immunobiology of Toll-like receptors: emerging trends, Immunol. Cell Biol, vol.84, pp.333-341, 2006. ,
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism, Carcinogenesis, vol.29, pp.1334-1342, 2008. ,
Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma, J. Oral Pathol. Med, vol.40, pp.187-193, 2011. ,
NF-kappaB functions as a tumour promoter in inflammation-associated cancer, Mediators Inflamm, vol.431, pp.461-466, 2004. ,
Increased expression of Toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia, 2011. ,
, Pathol. Oncol. Res. POR, vol.17, pp.677-683
The yin and yang of toll-like receptors in cancer, Oncogene, vol.33, pp.3485-3495, 2014. ,
Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer, Gastroenterology, vol.135, pp.518-528, 2008. ,
A family of human receptors structurally related to Drosophila Toll, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.588-593, 1998. ,
Absent toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma, J. Exp. Clin. Cancer Res. CR, vol.30, p.84, 2011. ,
Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation, Cancer Cell, vol.27, pp.27-40, 2015. ,
Toll-like receptor 3 expressed by melanoma cells as a target for therapy?, Clin. Cancer Res, vol.13, pp.4565-4574, 2007. ,
Intrapulmonary delivery of CpG microparticles eliminates lung tumors, Mol. Cancer Ther, vol.14, pp.2198-2205, 2015. ,
A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis, Nat. Cell Biol, vol.16, pp.1238-1248, 2014. ,
Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori, Int. J. Med. Microbiol. IJMM, vol.295, pp.179-185, 2005. ,
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, vol.410, pp.1107-1111, 2001. ,
Suppression of Toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma, Tumour Biol, vol.35, pp.9627-9637, 2014. ,
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.2066-2071, 2012. ,
Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells, Cancer Res, vol.69, pp.8710-8717, 2009. ,
Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5, Int. J. Mol. Med, vol.28, pp.115-119, 2011. ,
Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells, Leukemia, vol.20, pp.286-295, 2006. ,
A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia, Leukemia, vol.24, pp.222-226, 2010. ,
Assessment of expression of Toll-like receptors 2, 3 and 4 in laryngeal carcinoma, Eur. Arch. Oto-Rhino-Laryngol, vol.264, pp.525-530, 2007. ,
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack, Cancer Res, vol.69, pp.3105-3113, 2009. ,
PolyI:C-induced, TLR3/RIP3-dependent necroptosis backs up immune effector-Mediated tumor elimination in vivo, Cancer Immunol. Res, vol.3, pp.902-914, 2015. ,
Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development, Breast Edinb. Scotl, vol.21, pp.534-538, 2012. ,
Cancer and inflammation: an old intuition with rapidly evolving new concepts, Annu. Rev. Immunol, vol.30, pp.677-706, 2012. ,
, , 2012.
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8, J. Exp. Med, vol.202, pp.1575-1585, 2005. ,
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients, BMC Cancer, vol.10, p.415, 2010. ,
Circulating toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C, APMIS acta pathol. Microbiol. Immunol. Scand, vol.118, pp.261-270, 2010. ,
Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice, Hepatol. Baltim. Md, vol.57, pp.1869-1881, 2013. ,
Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells, Biochem. Biophys. Res. Commun, vol.379, pp.1027-1032, 2009. ,
Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model, Mol. Med. Rep, vol.8, pp.1037-1042, 2013. ,
A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo, BMC Cancer, vol.13, p.527, 2013. ,
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion, J. Exp. Clin. Cancer Res. CR, vol.29, p.92, 2010. ,
Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis, Front. Immunol, vol.9, pp.929-936, 2008. ,
Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis, Cancer Res, vol.68, pp.615-622, 2008. ,
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis, J. Exp. Med, vol.212, pp.2077-2094, 2015. ,
Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma, World J. Gastroenterol. WJG, vol.16, pp.2881-2888, 2010. ,
TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells, J. Immunol. Baltim. Md, vol.1950, issue.186, pp.1963-1969, 2011. ,
Functional expression of TLR9 in esophageal cancer, Oncol. Rep, vol.31, pp.2298-2304, 2014. ,
Toll-like receptor 5 agonist inhibition of growth of A549 lung cancer cells in vivo in a Myd88 dependent manner. Asian Pac, J. Cancer Prev. APJCP, vol.13, pp.2807-2812, 2012. ,
High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer, J. Cancer Res. Clin. Oncol, vol.140, pp.633-643, 2014. ,
TLR7/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma, Cancer Lett, vol.369, pp.298-306, 2015. ,
Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma, J. Hematol. Oncol, vol.8, p.21, 2015. ,